Home About Us Contact Us

 

Table of Content - Volume 4 Issue 1- October 2016


The proportion of cognitive impairment in patients with obstructive sleep apnoea

 

Nagabhushan D1, A K Badrinath2*, Sujitha Gurram3, K Vinoth4

 

{1Post Graduate, 2Professor, Department of General Medicine} {4Assistant Professor, Department of Psychiatry}

Sri Manakula Vinayagar Medical College and Hospital, Kalitheerthalkuppam, Puducherry, INDIA.

3Post Graduate, Department of Psychiatry, Mamata Medical College, Khammam, Telangana, INDIA.

Email: akbsts@yahoo.co.in

 

Abstract              Forty one patients with obstructive sleep apnoea had neuropsychologic testing prior to nocturnal sleep study in a sleep disorders clinic. The patients who had obstructive sleep apnoea with hypoxemia had more severe cognitive impairment than normal control subjects. Obstructive sleep apnoea had significantly poorer cognitive functioning on four of eight tests (p<0.005) In addition, the patients who had obstructive sleep apnoea had mean performance scores in the impaired range on measures of attention, concentration, complex problem-solving, and short-term recall of verbal and spatial information. In contrast, the normal healthy subjects had no mean performance score in the impaired range. The degree obstructive sleep apnoea during sleep and wakefulness significantly correlated with the degree of overall cognitive impairment t; however, measures of sleep fragmentation did not significantly correlate with overall cognitive impairment in patients with obstructive sleep apnoea. We conclude that patients who have obstructive sleep apnoea have cognitive impairment which is more severe than those normal healthy subjects.

Key Words: Obstructive sleep apnea; cognitive impairment; Mini mental scale.

 

INTRODUCTION

Obstructive sleep apnoea (OSA) is a common sleep disorder affecting about 2–4% of the adult population, with the highest prevalence reported among middle-aged men1. OSA is a very common disorder among obese individuals. OSA is characterized by repetitive episodes of complete or partial collapse of the upper airway (mainly the oropharyngeal tract) during sleep, by temporarily blocking the inflow of air2. These episodes lead to intermittent hypoxemia and fragmentation of sleep, which can give rise to variable cognitive impairments in OSA3. OSA is characterized by periodic complete or partial cessation of breathing while sleeping. These recurrent events of breathing result in fragmented sleep and recurrent hypoxemia (reductions in hemoglobin oxygen levels)4. It has been documented that OSA causes excessive daytime sleepiness, mood changes and dysfunctions in several cognitive domains5,6. However, there are different opinions on which cognitive abilities are affected mostly by OSA and on the exact nature of cognitive decline. The comparison of the findings of research studies is difficult because of differences in severity of disease, criteria that are used to assess the severity of syndromes and different sample sizes7. Other variables such as the sensitivity of neuropsychological battery chosen7 and different group ages are also confounding factors8. OSA is an increasingly common disorder in India with very high prevalence rate of 7.5%, associated with metabolic syndrome, upper body obesity with significant morbidity and mortality9. Patients with OSA show deficits across a wide range of cognitive functions including attention, memory, psychomotor speed and visuospatial abilities, constructional abilities, executive functions and language abilities10,11. The etiology of OSA is multifactorial, consisting of a complex interplay between anatomic, neuromuscular factors and an underlying genetic predisposition toward the disease. Cognitive changes in OSAS can be multiple and varied, including cognitive processing, memory, attention deficit, and executive functions7. Cognition is defined as all mental processes involved in acquisition, processing, storage and retrieval of information.12. Studies conducted previously to assess cognitive functions in OSA have shown variable results13. Attention and memory have been consistently shown to be affected in OSA. Hence, it becomes very important to assess effect of OSA on various cognitive domains in the Indian population. The present study was conducted to study the proportion of cognitive impairment in patients with obstructive sleep apnea.

 

MATERIALS AND METHODS

The present cross sectional study was conducted among the patients coming to the OPD and admitted at Department of General Medicine, Sri Manakula Vinayagar Medical College and Hospital, Kalitheerthalkuppam, with symptoms of obstructive sleep apnea. This study was carried with the prior approval from the Institutional Ethics Committee. Mini mental scale, a 30-point questionnaire is used in the present study to assess the prevalence of cognitive impairment in patients with obstructive sleep apnea.14 A total number of 41 individuals with recently diagnosed cases of OSA were selected as study group. Whereas, forty one healthy age, sex and education matched individuals in the age group of 18–59 years were selected as control group. All cases and controls were selected according to the inclusion/exclusion criteria. Cases and controls were explained in detail about the procedure to be performed in their vernacular language to their satisfaction. Written informed consent was obtained. Inclusion criteria for cases were as follows: (i) Apnea– hypopnea index > 5; (ii) ESS > 10. Inclusion criteria in controls to rule out OSA were as follows: (i) ESS < 10; (ii) Body mass index (BMI) < 30 kg/sq. m; (iii) Neck circumference < 40 cm; (iv) No history of snoring and tiredness; (v) No history of partners observation of apnea, choking and gasping during sleep; (vi) Systolic BP < 120 mm Hg, Diastolic BP < 80 mm Hg.

Statistical Analysis: Intergroup differences between OSA subjects and normal control were assessed using chi-square test and independent t-test. The generalized linear model for repeated measure analysis of variance (ANOVA) test adjusted for age and education years was used to analyze cognitive function measures. The statistical significance criterion was defined as a p value < 0.05 for two-tailed test. The level of significance for comparison of multiple neuropsychological tests was set at p < 0.0063 (= 0.05/8) according to Bonferroni correction. SPSS version 21.0 for Windows (SPSS Inc., Chicago, IL, USA) was used for statistical analysis.

 

RESULT

Baseline Clinical Characteristics between OSA subjects and normal control: Table 1 shows OSA subjects (n = 13) were older (t = 2.787, p = 0.008) and had lower education years (t = -2.419, p = 0.020) than normal control subjects (n = 28). The present also evaluated the parameters like Total sleep time, present results have clearly showed that, the total sleep time in control was 352 (43.8) whereas, the OSA subjects have showed 375 (54.8) which was not statistically no difference difference (p=0.389). The observations from Mean global AHI showed that the normal subjects have shown 51.7 (18.0) and OSA subjects have shown 46.8 (9.5) which is statistically insignificant (p=0.267). ESS score showed no difference between groups at baseline (t = 0.548, p = 0.588). After treatment, ESS score within OSA groups showed no significant difference, as compared to normal control (t = 0.482, p = 0.421).

 

Table 1: Baseline clinical characteristics between OSA subjects and normal control

 

Normal control

OSA subjects

p-value

Age (years)

65.1 (4.5)

69.6 (5.5)

0.008*

Gender (male)

20 (71.4%)

8 (61.5%)

0.818

Education (years)

14.8 (4.0)

11.2 (5.5)

0.020*

Total sleep time (min)

352 (43.8)

375 (54.8)

0.389

Mean global AHI (events/hr)

51.7 (18.0)

46.8 (9.5)

0.267

Epworth scale score

8.9 (6.0)

10.0 (4.5)

0.588

BMI (kg/m2)

25.8 (3.6)

24.3 (2.8)

0.203

Data are presented as mean (standard deviation) for continuous variables and number (%) for categorical variables. *p < 0.05, t-test or chi square test.AHI: apnea-hypopnea index, BMI: body mass index, OSA: obstructive sleep apnea.

Demographic and Clinical Characteristics: A total of 82 subjects participated in the study. Participants were divided two groups, OSA groups (n = 41) and normal healthy control (n = 41) (Table 2). Both groups were age and gender matched. Table 2 showed clinical characteristics and neuropsychological parameters of the study subjects. In the present study, neurocognitive function tests showed no significant differences between the normal and OSA subjects (p = 0.533). OSA groups had a decline of memory performance (DSF; t = -3.647, p = 0.001, DSB; t = -7.925, p < 0.001) with Bonferroni correction. The significant decline in the memory was seen in the DSF and DSB when compare with other parameters.

 

Table 2: Clinical characteristics and neuropsychological parameters in OSA subjects and normal control subjects

 

Normal control

OSA subjects

p-value

Age (years)

66.6 (5.1)

66.5 (5.2)

0.949

Gender (male)

28 (68.3%)

28 (68.3%)

1.000

Education (years)

13.4 (4.3)

13.7 (4.8)

0.810

BMI (kg/m2)

352 (43.8)

25.3 (3.4)

0.002*

AHI (events/hr)

4.8 (3.9)

50.1 (15.9)

< 0.001*

Neurocognitive function tests

MMSE-KC

27.4 (1.7)

27.0 (3.3)

0.533

Memory

DSF

8.1 (2.3)

6.5 (1.3)

0.001

DSB

6.7 (1.3)

4.1 (1.6)

< 0.001

WLR

5.7 (1.7)

5.9 (2.2)

0.569

CR

7.1 (2.5)

7.2 (2.7)

0.865

Data are presented as mean (standard deviation) for continuous variables and number (%) for categorical variables. *p < 0.05, independent t-test or chi square test. BMI: body mass index, AHI: apnea-hypopnea index, MMSE-KC: mini-mental state examination packet, DSF: digit span forward, DSB: digit span backward, WLR: word list recall, CR: constructional recall, OSA: obstructive sleep apnea. The OSA subjects had greater cognitive impairment than those normal control subjects. The OSA subjects had significantly poorer scores on four of eight tests than the normal control subjects (Table 3). In addition, the OSA subjects had mean scores within the cognitively impaired range on four of eight neuropsychologic measures when adjusted for their mean age and education. This number of mean test scores in the brain-impaired range was significantly greater (p<0.05) than that of the normal control subjects, which had no mean score in the impaired range. Cognitive functions in the impaired range for the OSA subjects with obstructive sleep apnea were attention and concentration, complex problem solving, short-term recall of verbal information (delay stories), and short-term recall of visuospatial information (delay designs).

 

Table 3: Cognitive Function Testing in OSA subjects and normal control subjects

Cognitive Function

Normal control

OSA subjects

General intellectual

20±1

18±3

Attention and concentration

90±7

126±20

Vigilance and eye/hand coordination

0.70±0.02

0.86±0.10

Rapid, complex problem-solving

108±6

89±12

Memory

Immediate recall/verbal

12±1

9±1

Delay recall/verbal

9±1

6±1

Immediate recall/visuospatial

14±1

10±2

Delay recall/visuospatial

10±2

6±2

Values are means± SE.

Participants’ raw scores were converted to t scores for each domain of cognitive function (speed of information processing; verbal, learning, memory, executive function; and working memory) and t scores were calculated. All t scores were adjusted for gender, age, education, during calculations. In a healthy population, a neurocognitive deficit (t score, 640) would be expected in 15% of participants. In our sample, 31% were impaired, showing a higher rate of impairment in our group. Table 4 shows average t scores and percent impairment for each domain.

Table 4: Mean (standard deviation) t scores and percent of participants classified as impaired. Higher t score indicated better performance

 

t score

% Impaired

Processing speed

48.2 (8.4)

16.3

Verbal fluency

48.6 (10.5)

20.4

Learning

44.2 (9.5)

36.7

Memory

45.9 (9.1)

24.5

Executive function

48.5 (9.5)

14.3

Working memory

50.1 (9.6)

14.3

 

DISCUSSION

The aim of this study was to assess cognitive function in moderate to severe OSA subjects. In comparison of characteristics, normal control presented older age and lower levels of education. At baseline, mild to severe OSA patients reported higher deficit of attention and working memory than normal healthy controls. Despite several inconsistent findings on the effect of OSA on memory functioning, delayed recall memory might be moderately impaired,6 and the domain of attention or executive functioning is substantially affected by OSA.15 Previously reported study decline of delayed recall and executive function in 42 OSA patients, as compared to 21 normal healthy subjects, indicating that cognition impairments are associated with severe OSA in elderly adults.16,17 However, present samples had higher education years and were younger in age. The cause of cognitive impairment in OSA patients is under discussion. Recent studies suggest that the decline of executive functions and visuospatial function might be related to severity of hypoxemia; whereas, the attention and memory deficit might be due to excessive daytime sleepiness resulting from sleep fragmentation.18 Although correlation analysis in this study was not done among daytime somnolence, measures of nocturnal hypoxemia and results of cognitions, frequent sleep fragmentation might be more effective on attention functioning in OSA groups as comparison of AHI. Two previous studies have described cognitive impairment in patients with sleep apnea19,20 One study reported significant relationships between cognitive performance and sleep-related respiratory disturbances in 41 elderly men.19 Impairment of visuospacial reasoning, memory, and psychomotor speed were positively correlated with the numbers of disturbed breathing events during sleep. The second study demonstrated cognitive impairment in 76 percent of patients with severe sleep apnea.20 These patients had deficits in thinking, perception, memory, communication, and the ability to learn new information. The lack of significant linear correlation between variables reflecting sleep fragmentation and overall cognitive impairment does not exclude a role of sleep fragmentation in producing cognitive impairment. Both groups have marked sleep fragmentation, and a threshold effect could be present21 Although this study shows statistically significant correlations between overall cognitive impairment and measures of both groups, no direct role of hypoxemia as a cause of cognitive dysfunction is proven. Further studies using either daytime or nocturnal oxygen supplementation may help to define the relative importance of awake and sleeping hypoxemia in maintaining cognitive functioning in patients with sleep apnea. In this context, the finding that cortisol levels are associated with neurocognitive function in patients with OSA may be related to the possible role of cortisol in hippocampal volume loss observed in the neuroimaging studies of individuals with OSA22. Interestingly, some studies found that it was nighttime levels that were important for neurocognitive function, rather than 24-h or daytime levels of cortisol. This finding in a sleep disorder setting is worthy of attention. The study of memory function has revealed the importance of sleep and nighttime HPA activity. Plihal and Born23 experimentally manipulated cortisol levels during sleep and showed that elevated cortisol levels impaired declarative memory after only one single night. Given the evidence linking long-term elevated cortisol levels to atrophy in hippocampi and cerebral cortex, the examination of resting or nighttime cortisol levels on cognition is particularly informative24-26. The negative impact of cortisol on cognitive performance has been linked to elevated nightly nadir levels of this hormone27. Born and Wagner28 showed that declarative memories, the formation of which involves the hippocampus, benefit from the inhibition of endogenous cortisol during early sleep, though an increased level of endogenous cortisol was associated with reduced emotional memory retention. The authors proposed that the effect of circulating cortisol on the glucocorticoid receptors in the hippocampus impacts memory formation during sleep28. Our study examined the associations between OSA, cognitive function. In addition to the expected finding that increasing severity of OSA was associated with reductions in neurocognitive functioning. Importantly, even after controlling for potential confounding factors, night time sleep duration were a significant predictor of neurocognitive functioning, though OSA severity was not related. Several specific domains of neurocognitive functioning were particularly related to nighttime sleep, with night time sleep duration accounting for up to 16% of the variance in the domains of learning, memory, and working memory. The finding that nighttime sleep duration was a significant predictor of neurocognitive function over and above indices of OSA severity is important, as it allows speculation that perhaps it not apnea per say, but rather the physiologic responses to apnea (in particular HPA activity) that provide the proximal association with neurocognitive impairment.

 

REFERENCES

  1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 32: 1230–1235.
  2. Guilleminault C., Quo S. (2001) Sleep-disordered breathing. A view at the beginning of the new Millennium. Dent Clin North Am 45: 643–65.
  3. Fishman, A., Elias, J. and Fishman, J., Sleep apnea syndrome (2008). In Pulmonary Diseases and Disorders, McGraw-Hill, USA, 4th edn, pp. 1698–1276.
  4. American Academy of Sleep Medicine Task Force. (1999). Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep, Vol. 22, No. 5, (August 1999), pp.667-689, ISSN 0161-8105.
  5. Engleman, H. & Joffe, D. (1999). Neuropsychological function in obstructive sleep apnoea. Sleep Medicine, Vol. 3, No. 1, (March 1999), pp. 59-78, ISSN 1087-0792,
  6. Tsara, V., Kaimakamis, E., Serasli, E., Katsarou, Z. & Christaki, P. (2009). Health related of life in Greek patients with sleep apnea-hypopnea syndrome treated with continuous positive airway pressure. Sleep Medicine, Vol. 10, No. 2, (February 2009), pp. 217-225, ISSN 1389-9457
  7. Quan, S. F., Wright, R., Baldwin, C.M., Kaemingk, K.L., Goodwin, J.L., Kuo, T.F., Kaszniak, A., Boland, L.L., Caccappolo, E. & Bootzin, R.R. (2006). Obstructive sleep apneahypopnea and neurocognitive functioning in the sleep heart health study. Sleep Medicine, Vol. 7, No.6, (September 2006), pp. 498-507, ISSN 1389-9457.
  8. Mathieu, A., Mazza, S., Decary, A., Massicotte-Marquez, J., Petit, D., Gosselin, N., Malo, J. & Montplaisir, J. (2008). Effects of obstructive sleep apnea on cognitive function: A comparison between younger and older OSAS patients. Sleep Medicine, Vol. 9, No. 2, (January 2008), pp. 112-120, ISSN 1389-9457.
  9. Young, T. (2009), Rationale, design and findings from the Wisconsin Sleep Cohort Study: Toward understanding the total societal burden of sleep disordered breathing. Sleep Med. Clin., 4(1), 37–46.
  10. Andreou. G. & Agapitou, P. (2007). Reduced language abilities in adolescents who snore. Archives of Clinical Neuropsychology, Vol. 22, No. 2, (February 2007), pp. 225 – 9, ISSN 0887-6177; Engleman & Joffe, 1999; Findley et al., 1986
  11. Engleman, H. & Joffe, D. (1999). Neuropsychological function in obstructive sleep apnoea. Sleep Medicine, Vol. 3, No. 1, (March 1999), pp. 59-78, ISSN 1087-0792.
  12. Lezak, M. and Howieson, D. (2004), A compendium of tests and assessment techniques. In Neuropsychological Assessment, Oxford University Press, USA, pp. 335–680.
  13. Sforza E , Roche F (2012). Sleep apnea syndrome and cognition. Front Neurol . 3 : 87
  14. Folstein, M., Folstein, S.E., McHugh, P.R. (1975). “Mini-Mental State” a Practical Method for Grading the Cognitive State of Patients for the Clinician. Journal of Psychiatric Research, 12(3); 189-198.
  15. Beebe DW, Groesz L, Wells C, Nichols A, McGee K (2003). The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. Sleep; 26:298-307.
  16. Matthews EE, Aloia MS (2011). Cognitive recovery following positive airway pressure (PAP) in sleep apnea. Prog Brain Res; 190:71-88.
  17. Ju G, Yoon IY, Lee SD, Kim TH, Choe JY, Kim KW (2012). Effects of sleep apnea syndrome on delayed memory and executive function in elderly adults. J Am Geriatr Soc; 60:1099-103.
  18. Lal C, Strange C, Bachman D (2012). Neurocognitive impairment in obstructive sleep apnea. Chest; 141:1601-10.
  19. Yesavage J, Bliwise D, Guilleminault C, Carskadon M, Dement W (1985). Preliminary communication: intellectual deficit and sleeprelated respiratory disturbance in the elderly. Sleep; 8:30-3
  20. Kales A, Caldwell A, Cadieux R, Vela-Bueno A, Ruch L, Mayes S (1985). Severe obstructive sleep apnea: II. Associated psychopathology and psychosocial consequences. J Chronic Dis; 38:427-34
  21. Kety S, Schmidt C (1948). The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood Bow and cerebral oxygen consumption of normal young men. J Clin Invest; 1:1:484-92
  22. Macey PM, Henderson LA, Macey KE, Alger JR, Frysinger RC, Woo MA, et al (2002). Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med; 166:1382–7.
  23. Plihal W, Born J (1999). Memory consolidation in human sleep depends on inhibition of glucocorticoid release. Neuroreport; 10:2741–7.
  24. Rothschild AJ, Benes F, Hebben N, Woods B, Luciana M, Bakanas E, et al (1989). Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients. Biol Psychiatry; 26:565–75.
  25. Sapolsky RM (1985). Glucocorticoid toxicity in the hippocampus: temporal aspects of neuronal vulnerability. Brain Res; 359:300–5.
  26. Karlamangla AS, Singer BH, Chodosh J, McEwen BS, Seeman TE (2005). Urinary cortisol excretion as a predictor of incident cognitive impairment. Neurobiol Aging; (26 suppl 1):S80–4.
  27. Belanoff JK, Gross K, Yager A, Schatzberg AF (2001). Corticosteroids and cognition. J Psychiatr Res; 35:127–45.
  28. Born J, Wagner U (2004). Memory consolidation during sleep: role of cortisol feedback. Ann N Y Acad Sci; 1032:198–201.

 

 

 


 

 

 




Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.